Treatment results in males with breast cancer |
| |
Authors: | B. Pakisch H. Stoeger H. Poschauko H. Samonigg T. Bauernhofer E. Pojer H. Leitner G. Stuecklschweiger K. H. Peichl F. Quehenberger A. Hackl |
| |
Affiliation: | (1) Department of Radiotherapy, Karl Franzens University of Graz, Auenbruggerplatz 9, A-8036 Graz, Austria;(2) Department of Clinical Oncology, Karl Franzens University of Graz, Auenbruggerplatz 9, A-8036 Graz, Austria;(3) Department of Statistics and Documentation, Karl Frazens University of Graz, Auenbruggerplatz 9, A-8036 Graz, Austria |
| |
Abstract: | Because cancer of the male breast is rare knowledge about its biology and behavior is essentially due to a compilation of pooled experiences. Hence, a continued report of cases appears to be important. Therefore a retrospective review of patients suffering from male breast cancer was carried out. Twenty-four evaluable cases were analyzed. Eight patients (1 patient with bilateral Stage I carcinoma was included) were in Stage I, 7 in Stage II, 2 in Stage IIIa, 4 in Stage IIIb, and 3 in Stage IV. Of 23 patients who were treated with mastectomy, 22 had modified radical mastectomy and postoperative irradiation to the chest wall as well as to the peripheral lymphatic areas in most cases. One patient underwent radical mastectomy. Another patient had an excision biopsy only, followed by irradiation. One of 24 patients received tamoxifen; another received cyclophosphamide, methotrexate, 5-fluorouracil, predisone (CMF) regimen in an adjuvant setting. Local recurrence developed in one of 23 (4%) patients treated with mastectomy and radiation therapy to the chest wall and peripheral lymphatics. Four (17%) patients developed distant metastases. The 5-year overall survival (Kaplan-Maier) was 90% for the entire group, 100% for patients in Stage I–III disease, and 60% in Stage IV disease (P = <0.005). As observed in former reports the stage of disease at initial presentation seems to be a parameter that significantly contributes to survival in male breast cancer patients. To what extent improved local control by adequate local therapy, such as surgery and postoperative radiotherapy, may improve overall survival remains to be discussed.Correspondnce to: B. Pakisch |
| |
Keywords: | Male breast cancer Surgery Radiation theraphy Prognosis |
本文献已被 SpringerLink 等数据库收录! |
|